Alexandra MacLean - 23 Sep 2024 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ATXI
Reported as of: 23 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Sep 2024, 16:55:21 UTC
Prior SEC filing: 03 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ David Jin, Attorney-in-Fact

Key filing fact

Alexandra MacLean filed Form 4 for AVENUE THERAPEUTICS, INC. (ATXI) on 25 Sep 2024.

Key facts

This page summarizes Alexandra MacLean's Form 4 filing for AVENUE THERAPEUTICS, INC. (ATXI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Sep 2024, 16:55.

Change

Previous filing in this sequence was filed on 03 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATXI transaction

COMMON STOCK, PAR VALUE $0.0001

Award

Transaction value: $0
Shares: +170,000
Change %
Price: $0.000000
Shares after: 170,000
Date: 23 Sep 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of 170,000 restricted stock units which will vest in equal installments at September 30, 2024, December 31, 2024, September 23, 2025, and September 23, 2026. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and Change in Control events (as defined in the Avenue Therapeutics, Inc. 2015 Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.